Biogen will acquire a drug company for $5.6 billion to expand work in kidney diseases

By:
On:
URL has been copied successfully!
Biogen, already developing a drug that can be used to treat several kidney disorders, is paying a large premium for Apellis Pharmaceuticals
Please follow us:
Follow by Email
X (Twitter)
Whatsapp
LinkedIn
Copy link

This post was originally published here.